Our Service Catalogue is divided into two distinct parts to clearly demarcate tests covered under NABL accreditation and those that are not. Tests are grouped based on their NABL accreditation status.
B–RAF exon 15 sequencing (V600E)
Specimen
FFPE block
Type of test
Diagnostic & Predictive
Organ
Department/ Section
Molecular Diagnostics
SYT–SSX translocation by PCR
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Molecular Diagnostics
EWS–FLI–1 translocation by RT PCR
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Molecular Diagnostics
Cancer Hotspot Mutation analysis by NGS (Solid tumour)
Specimen
FFPE block
Type of test
Prognostic, Predictive
Organ
Department/ Section
Molecular Diagnostics
T cell receptor (gamma) gene receptor rearrangement study
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Molecular Diagnostics
T cell receptor (beta) gene receptor rearrangement study
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Molecular Diagnostics
IgH gene receptor rearrangement study
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Molecular Diagnostics
ETV6–NTRK 3 translocation by RT PCR
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Molecular Diagnostics
EWS–WT1 translocation by RT PCR
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Molecular Diagnostics
ATF1–CREB–1 translocation by RT PCR
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Molecular Diagnostics
Whole Slide Imaging (WSI)
Specimen
Stained slides
Type of test
Organ
Department/ Section
Histopathology
Colon Carcinoma Panel (Cancer Hotspot Mutation Panel by NGS + MMR by IHC)
Specimen
FFPE block with tumour cellularity of more than 10%
Type of test
Diagnostic, Predictive, Prognostic
Organ
Colon / Intestine
Department/ Section
Histopathology / Molecular Diagnostics
Lung Carcinoma Panel (Lung Biopsy Review + 52 gene Focus NGS Panel + PDL–1 by IHC)
Specimen
FFPE block with tumour cellularity of more than 10%
Type of test
Diagnostic, Predictive, Prognostic
Organ
Lung
Department/ Section
Histopathology / Molecular Diagnostics
Endometrial Carcinoma Panel (P53 by IHC + POLE + MMR by IHC)
Specimen
FFPE block with tumour cellularity of more than 10%
Type of test
Diagnostic, Predictive, Prognostic
Organ
Uterus
Department/ Section
Histopathology / Molecular Diagnostics
TERT gene promoter mutation test
Specimen
FFPE block with tumour cellularity of more than 10%
Type of test
Diagnostic, Prognostic
Organ
Brain
Department/ Section
Molecular Diagnostics
HPV DNA high risk extended genotyping detection assay (FDA & CE IVD approved) – Self collection kit
Specimen
Sample collected in FLOQ Vaginal swabs
Type of test
Diagnostic, Screening
Organ
Cervix
Department/ Section
Molecular Diagnostics
HPV DNA high risk extended genotyping detection assay (FDA & CE IVD approved) – LBC Collection vial
Specimen
Cervical brush scrapped material in Surepath LBC vial
Type of test
Diagnostic, Screening
Organ
Cervix
Department/ Section
Molecular Diagnostics
TP53 gene Mutation assay
Specimen
FFPE blocks with tumour cellularity of more than 20%
Type of test
Prognostic & Predictive
Organ
Department/ Section
Molecular Diagnostics
PIK3CA mutation detection assay (Exon 7, 9, 20)
Specimen
FFPE block with tumour cellularity of more than 10%
Type of test
Prognostic & Predictive
Organ
Department/ Section
Molecular Diagnostics
IDH 1 & 2 (Isocitrate Dehydrogenase 1 & 2) gene mutation detection assay
Specimen
Type of test
Diagnostic
Organ
Brain
Department/ Section
Molecular Diagnostics